NDC properties for NDC 9 0378-1936
NDC item 00378193601
NDC 9 | 0378-1936 |
---|---|
NDC 10 | 0378-1936-01 |
NDC Item | 00378193601 |
packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-01) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 00378193628
NDC 9 | 0378-1936 |
---|---|
NDC 10 | 0378-1936-28 |
NDC Item | 00378193628 |
packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1936-28) |
ANDA | ANDA213912 |
COLORTEXT | WHITE(white opaque) |
Color | C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 00480124228
NDC 9 | 0480-1242 |
---|---|
NDC 10 | 0480-1242-28 |
NDC Item | 00480124228 |
packaging | 28 CAPSULE in 1 BOTTLE (0480-1242-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 644159 |
Imprint code | NAT;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 31722025801
NDC 9 | 31722-258 |
---|---|
NDC 10 | 31722-258-01 |
NDC Item | 31722025801 |
packaging | 100 CAPSULE in 1 BOTTLE (31722-258-01) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L2 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 31722025828
NDC 9 | 31722-258 |
---|---|
NDC 10 | 31722-258-28 |
NDC Item | 31722025828 |
packaging | 28 CAPSULE in 1 BOTTLE (31722-258-28) |
ANDA | ANDA212414 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L2 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 43598051101
NDC 9 | 43598-511 |
---|---|
NDC 10 | 43598-511-01 |
NDC Item | 43598051101 |
packaging | 100 CAPSULE in 1 BOTTLE (43598-511-01) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
NDC item 43598051163
NDC 9 | 43598-511 |
---|---|
NDC 10 | 43598-511-63 |
NDC Item | 43598051163 |
packaging | 28 CAPSULE in 1 BOTTLE (43598-511-63) |
ANDA | ANDA209348 |
COLORTEXT | WHITE(opaque white colored cap and body) |
Color | C48325 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
NDC item 47781048401
NDC 9 | 47781-484 |
---|---|
NDC 10 | 47781-484-01 |
NDC Item | 47781048401 |
packaging | 100 CAPSULE in 1 BOTTLE (47781-484-01) |
ANDA | ANDA210480 |
COLORTEXT | GREEN,YELLOW(light caramel) |
Color | C48329;C48330 __ |
FDA SPL set id | 789803 |
Imprint code | LP;638 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 47781048428
NDC 9 | 47781-484 |
---|---|
NDC 10 | 47781-484-28 |
NDC Item | 47781048428 |
packaging | 28 CAPSULE in 1 BOTTLE (47781-484-28) |
ANDA | ANDA210480 |
COLORTEXT | GREEN,YELLOW(light caramel) |
Color | C48329;C48330 __ |
FDA SPL set id | 789803 |
Imprint code | LP;638 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 59651034301
NDC 9 | 59651-343 |
---|---|
NDC 10 | 59651-343-01 |
NDC Item | 59651034301 |
packaging | 100 CAPSULE in 1 BOTTLE (59651-343-01) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 59651034307
NDC 9 | 59651-343 |
---|---|
NDC 10 | 59651-343-07 |
NDC Item | 59651034307 |
packaging | 1 BLISTER PACK in 1 CARTON (59651-343-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 59651034328
NDC 9 | 59651-343 |
---|---|
NDC 10 | 59651-343-28 |
NDC Item | 59651034328 |
packaging | 28 CAPSULE in 1 BOTTLE (59651-343-28) |
ANDA | ANDA213885 |
COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
Color | C48325 __ |
FDA SPL set id | 717399 |
Imprint code | L;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 60505453301
NDC 9 | 60505-4533 |
---|---|
NDC 10 | 60505-4533-1 |
NDC Item | 60505453301 |
packaging | 100 CAPSULE in 1 BOTTLE (60505-4533-1) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
NDC item 60505453302
NDC 9 | 60505-4533 |
---|---|
NDC 10 | 60505-4533-2 |
NDC Item | 60505453302 |
packaging | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(white opaque),WHITE(white opaque) |
Color | C48325;C48325 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
NDC item 63304004201
NDC 9 | 63304-042 |
---|---|
NDC 10 | 63304-042-01 |
NDC Item | 63304004201 |
packaging | 100 CAPSULE in 1 BOTTLE (63304-042-01) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;79 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 63304004227
NDC 9 | 63304-042 |
---|---|
NDC 10 | 63304-042-27 |
NDC Item | 63304004227 |
packaging | 28 CAPSULE in 1 BOTTLE (63304-042-27) |
ANDA | ANDA211846 |
COLORTEXT | WHITE,WHITE |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;79 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-04 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 69097038173
NDC 9 | 69097-381 |
---|---|
NDC 10 | 69097-381-73 |
NDC Item | 69097038173 |
packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) |
ANDA | ANDA210435 |
COLORTEXT | WHITE(printed in black-ink) |
Color | C48325 __ |
FDA SPL set id | 698711 |
Imprint code | Cipla5mg;381 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |
NDC item 70710103101
NDC 9 | 70710-1031 |
---|---|
NDC 10 | 70710-1031-1 |
NDC Item | 70710103101 |
packaging | 100 CAPSULE in 1 BOTTLE (70710-1031-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with white opaque body) |
Color | C48325 __ |
FDA SPL set id | 770365 |
Imprint code | 1031 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
NDC item 70710103107
NDC 9 | 70710-1031 |
---|---|
NDC 10 | 70710-1031-7 |
NDC Item | 70710103107 |
packaging | 28 CAPSULE in 1 BOTTLE (70710-1031-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with white opaque body) |
Color | C48325 __ |
FDA SPL set id | 770365 |
Imprint code | 1031 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
NDC item 70771167701
NDC 9 | 70771-1677 |
---|---|
NDC 10 | 70771-1677-1 |
NDC Item | 70771167701 |
packaging | 100 CAPSULE in 1 BOTTLE (70771-1677-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with white opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1031 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
NDC item 70771167707
NDC 9 | 70771-1677 |
---|---|
NDC 10 | 70771-1677-7 |
NDC Item | 70771167707 |
packaging | 28 CAPSULE in 1 BOTTLE (70771-1677-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with white opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1031 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-12 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
NDC item 76282069748
NDC 9 | 76282-697 |
---|---|
NDC 10 | 76282-697-48 |
NDC Item | 76282069748 |
packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-697-48) |
ANDA | ANDA210435 |
COLORTEXT | WHITE(printed in black-ink) |
Color | C48325 __ |
FDA SPL set id | 792852 |
Imprint code | Cipla5mg;381 |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 18 mm |